Step up to 802.11be Wi-Fi 7 for under $200 with the new U7 Pro ceiling-mounted access point from Ubiquiti. Join us as we test ...
Sorry, we don't have any stock of this product. Please click 'Notify Me' and we will let you know when the item is available.
Ubiquiti consists of three principal divisions: Service Provider (carrier-class, long-haul links), Enterprise (reliable business-class networks), and Consumer (intuitive devices for the connected ...
AC-225 is suitable for applications with up to 30,000 users across a modular 2,000 doors, allowing maximum flexibility for securing a growing enterprise. Each AC-225 Access Control Unit ... local or ...
Avigilon AC-PRO-KIT16 Access Control Manager 16-door Professional kit Avigilon AC-PRO-KIT4 Access Control Manager 4-door Professional kit Avigilon AC-PRO-KIT8 Access Control Manager 8-door ...
“There’s a framework deal. The Israelis have more or less accepted it,” a senior US official in the administration of President Joe Biden told reporters on a conference call. “Right ...
Whether you are a regular user or have never visited, your opinions are vital to us. We'd be really grateful if you could ... SCHARR library is open to all SCHARR staff and students, offering access ...
or bbl-info@bristol.ac.uk (samples). Request access to the ALSPAC study history archive Use of the ALSPAC study history archive is subject to approval from the ALSPAC Executive Committee. For more ...
And in 2020, we brought the sector together to create a nine point plan looking at practical recommendations to improve access to new cancer treatments ... We met Rob Lester who told us about his ...
The range of colours an animal sees depends on the combination ... Other cells in our eyes, called rod cells, help us see in dim light. But because rod cells only have a single light-sensitive pigment ...
please email wellbeing-access@bristol.ac.uk. You can also call us on +44 (0)117 456 9860*. Our phone line is accessible 24 hours a day, 7 days a week. *All calls are recorded and kept for up to 12 ...
Our 2021 report, Clinical trials in cancer, reveals the impact of the Covid-19 pandemic on cancer trials and highlights longstanding barriers to expanding clinical trial access to more people with ...